Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Sodium oxybate - Jazz Pharmaceuticals

Next Previous
X
Search
Drug Profile

Sodium oxybate - Jazz Pharmaceuticals

Alternative Names: Gamma-hydroxybutyrate; JZP-6; KEY-10; NSC-84223; Xyrem

Latest Information Update: 11 Mar 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Jazz Pharmaceuticals
  • Developer Bausch Health Companies; Jazz Pharmaceuticals; Jazz Pharmaceuticals Inc; Jazz Pharmaceuticals plc; UCB
  • Class Butyric acids; Hydroxybutyrates; Sleep disorder therapies; Small molecules
  • Mechanism of Action Dopamine receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Narcolepsy; Cataplexy
  • New Molecular Entity No

Highest Development Phases

  • Marketed Cataplexy; Narcolepsy
  • Discontinued Essential tremor; Fibromyalgia

Most Recent Events

  • 08 Mar 2024 Launched for Cataplexy in United Kingdom (PO) (Jazz Pharmaceuticals SEC filing, Form 10-K, March 2024)
  • 07 Mar 2024 Registered for Cataplexy in United Kingdom (PO) (Jazz Pharmaceuticals SEC filing, Form 10-K, March 2024)
  • 01 May 2021 Jazz Pharmaceuticals has patent protection for sodium oxybate in USA

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top